---
document_datetime: 2025-12-02 06:37:34
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/medicines/human/EPAR/optaflu.html
document_name: optaflu.html
version: success
processing_time: 0.1207463
conversion_datetime: 2025-12-23 23:47:04.95742
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
# Optaflu

[RSS](/en/individual-human-medicine.xml/66837)

##### Expired

This medicine's authorisation has expired

influenza vaccine (surface antigen, inactivated, prepared in cell cultures) Medicine Human Expired

Page contents

## Page contents

- [Overview](#overview)
- [Product information](#product-info)
- [Product details](#product-details)
- [Authorisation details](#authorisation-details)
- [Assessment history](#assessment-history)
- [More information on Optaflu](#related-medicines)

- Application under evaluation
- CHMP opinion
- European Commission decision

## Overview

The marketing authorisation for Optaflu [influenza vaccine (surface antigen, inactivated, prepared in cell cultures)] expired on 5 June 2017 following the decision of the marketing authorisation holder, Seqirus GmbH, not to apply for a renewal of the marketing authorisation. Seqirus GmbH confirmed that it did not apply for renewal of the authorisation due to commercial reasons.

Optaflu was granted marketing authorisation in the European Union (EU) on 1 June 2007 for prophylaxis of influenza for adults. The marketing authorisation was valid for a 5-year period. It was subsequently renewed for an additional 5-year period in 2012.

The European Public Assessment Report (EPAR) for Optaflu is updated accordingly to reflect the fact that the marketing authorisation is no longer valid.

Optaflu : EPAR - Summary for the public

English (EN) (542.1 KB - PDF)

**First published:** 22/02/2008

**Last updated:** 02/12/2015

[View](/en/documents/overview/optaflu-epar-summary-public_en.pdf)

[Other languages (22)](#file-language-dropdown-101)

български (BG) (626.94 KB - PDF)

**First published:**

22/02/2008

**Last updated:**

02/12/2015

[View](/bg/documents/overview/optaflu-epar-summary-public_bg.pdf)

español (ES) (543.18 KB - PDF)

**First published:**

22/02/2008

**Last updated:**

02/12/2015

[View](/es/documents/overview/optaflu-epar-summary-public_es.pdf)

čeština (CS) (607.18 KB - PDF)

**First published:**

22/02/2008

**Last updated:**

02/12/2015

[View](/cs/documents/overview/optaflu-epar-summary-public_cs.pdf)

dansk (DA) (542.38 KB - PDF)

**First published:**

22/02/2008

**Last updated:**

02/12/2015

[View](/da/documents/overview/optaflu-epar-summary-public_da.pdf)

Deutsch (DE) (544.72 KB - PDF)

**First published:**

22/02/2008

**Last updated:**

02/12/2015

[View](/de/documents/overview/optaflu-epar-summary-public_de.pdf)

eesti keel (ET) (569.2 KB - PDF)

**First published:**

22/02/2008

**Last updated:**

02/12/2015

[View](/et/documents/overview/optaflu-epar-summary-public_et.pdf)

ελληνικά (EL) (632.08 KB - PDF)

**First published:**

22/02/2008

**Last updated:**

02/12/2015

[View](/el/documents/overview/optaflu-epar-summary-public_el.pdf)

français (FR) (544.92 KB - PDF)

**First published:**

22/02/2008

**Last updated:**

02/12/2015

[View](/fr/documents/overview/optaflu-epar-summary-public_fr.pdf)

hrvatski (HR) (565.37 KB - PDF)

**First published:**

22/02/2008

**Last updated:**

02/12/2015

[View](/hr/documents/overview/optaflu-epar-summary-public_hr.pdf)

italiano (IT) (542.06 KB - PDF)

**First published:**

22/02/2008

**Last updated:**

02/12/2015

[View](/it/documents/overview/optaflu-epar-summary-public_it.pdf)

latviešu valoda (LV) (606.25 KB - PDF)

**First published:**

22/02/2008

**Last updated:**

02/12/2015

[View](/lv/documents/overview/optaflu-epar-summary-public_lv.pdf)

lietuvių kalba (LT) (568.74 KB - PDF)

**First published:**

22/02/2008

**Last updated:**

02/12/2015

[View](/lt/documents/overview/optaflu-epar-summary-public_lt.pdf)

magyar (HU) (604.87 KB - PDF)

**First published:**

22/02/2008

**Last updated:**

02/12/2015

[View](/hu/documents/overview/optaflu-epar-summary-public_hu.pdf)

Malti (MT) (612.39 KB - PDF)

**First published:**

22/02/2008

**Last updated:**

02/12/2015

[View](/mt/documents/overview/optaflu-epar-summary-public_mt.pdf)

Nederlands (NL) (542.82 KB - PDF)

**First published:**

22/02/2008

**Last updated:**

02/12/2015

[View](/nl/documents/overview/optaflu-epar-summary-public_nl.pdf)

polski (PL) (607.38 KB - PDF)

**First published:**

22/02/2008

**Last updated:**

02/12/2015

[View](/pl/documents/overview/optaflu-epar-summary-public_pl.pdf)

português (PT) (543.41 KB - PDF)

**First published:**

22/02/2008

**Last updated:**

02/12/2015

[View](/pt/documents/overview/optaflu-epar-summary-public_pt.pdf)

română (RO) (568.85 KB - PDF)

**First published:**

22/02/2008

**Last updated:**

02/12/2015

[View](/ro/documents/overview/optaflu-epar-summary-public_ro.pdf)

slovenčina (SK) (609.36 KB - PDF)

**First published:**

22/02/2008

**Last updated:**

02/12/2015

[View](/sk/documents/overview/optaflu-epar-summary-public_sk.pdf)

slovenščina (SL) (598.68 KB - PDF)

**First published:**

22/02/2008

**Last updated:**

02/12/2015

[View](/sl/documents/overview/optaflu-epar-summary-public_sl.pdf)

Suomi (FI) (542.05 KB - PDF)

**First published:**

22/02/2008

**Last updated:**

02/12/2015

[View](/fi/documents/overview/optaflu-epar-summary-public_fi.pdf)

svenska (SV) (542.7 KB - PDF)

**First published:**

22/02/2008

**Last updated:**

02/12/2015

[View](/sv/documents/overview/optaflu-epar-summary-public_sv.pdf)

## Product information

Optaflu : EPAR - Product Information

English (EN) (692.01 KB - PDF)

**First published:** 11/05/2009

**Last updated:** 13/02/2017

[View](/en/documents/product-information/optaflu-epar-product-information_en.pdf)

[Other languages (24)](#file-language-dropdown-88)

български (BG) (1.44 MB - PDF)

**First published:**

11/05/2009

**Last updated:**

13/02/2017

[View](/bg/documents/product-information/optaflu-epar-product-information_bg.pdf)

español (ES) (709.15 KB - PDF)

**First published:**

11/05/2009

**Last updated:**

13/02/2017

[View](/es/documents/product-information/optaflu-epar-product-information_es.pdf)

čeština (CS) (1.14 MB - PDF)

**First published:**

11/05/2009

**Last updated:**

13/02/2017

[View](/cs/documents/product-information/optaflu-epar-product-information_cs.pdf)

dansk (DA) (697.84 KB - PDF)

**First published:**

11/05/2009

**Last updated:**

13/02/2017

[View](/da/documents/product-information/optaflu-epar-product-information_da.pdf)

Deutsch (DE) (713.45 KB - PDF)

**First published:**

11/05/2009

**Last updated:**

13/02/2017

[View](/de/documents/product-information/optaflu-epar-product-information_de.pdf)

eesti keel (ET) (693.64 KB - PDF)

**First published:**

11/05/2009

**Last updated:**

13/02/2017

[View](/et/documents/product-information/optaflu-epar-product-information_et.pdf)

ελληνικά (EL) (1.5 MB - PDF)

**First published:**

11/05/2009

**Last updated:**

13/02/2017

[View](/el/documents/product-information/optaflu-epar-product-information_el.pdf)

français (FR) (716.14 KB - PDF)

**First published:**

11/05/2009

**Last updated:**

13/02/2017

[View](/fr/documents/product-information/optaflu-epar-product-information_fr.pdf)

hrvatski (HR) (759.7 KB - PDF)

**First published:**

11/05/2009

**Last updated:**

13/02/2017

[View](/hr/documents/product-information/optaflu-epar-product-information_hr.pdf)

íslenska (IS) (702.84 KB - PDF)

**First published:**

11/05/2009

**Last updated:**

13/02/2017

[View](/is/documents/product-information/optaflu-epar-product-information_is.pdf)

italiano (IT) (706.73 KB - PDF)

**First published:**

11/05/2009

**Last updated:**

13/02/2017

[View](/it/documents/product-information/optaflu-epar-product-information_it.pdf)

latviešu valoda (LV) (1.21 MB - PDF)

**First published:**

11/05/2009

**Last updated:**

13/02/2017

[View](/lv/documents/product-information/optaflu-epar-product-information_lv.pdf)

lietuvių kalba (LT) (810.2 KB - PDF)

**First published:**

11/05/2009

**Last updated:**

13/02/2017

[View](/lt/documents/product-information/optaflu-epar-product-information_lt.pdf)

magyar (HU) (1.12 MB - PDF)

**First published:**

11/05/2009

**Last updated:**

13/02/2017

[View](/hu/documents/product-information/optaflu-epar-product-information_hu.pdf)

Malti (MT) (1.14 MB - PDF)

**First published:**

11/05/2009

**Last updated:**

13/02/2017

[View](/mt/documents/product-information/optaflu-epar-product-information_mt.pdf)

Nederlands (NL) (709.21 KB - PDF)

**First published:**

11/05/2009

**Last updated:**

13/02/2017

[View](/nl/documents/product-information/optaflu-epar-product-information_nl.pdf)

norsk (NO) (696.27 KB - PDF)

**First published:**

11/05/2009

**Last updated:**

13/02/2017

[View](/no/documents/product-information/optaflu-epar-product-information_no.pdf)

polski (PL) (1.19 MB - PDF)

**First published:**

11/05/2009

**Last updated:**

13/02/2017

[View](/pl/documents/product-information/optaflu-epar-product-information_pl.pdf)

português (PT) (705.71 KB - PDF)

**First published:**

11/05/2009

**Last updated:**

13/02/2017

[View](/pt/documents/product-information/optaflu-epar-product-information_pt.pdf)

română (RO) (814.95 KB - PDF)

**First published:**

11/05/2009

**Last updated:**

13/02/2017

[View](/ro/documents/product-information/optaflu-epar-product-information_ro.pdf)

slovenčina (SK) (1.13 MB - PDF)

**First published:**

11/05/2009

**Last updated:**

13/02/2017

[View](/sk/documents/product-information/optaflu-epar-product-information_sk.pdf)

slovenščina (SL) (1.12 MB - PDF)

**First published:**

11/05/2009

**Last updated:**

13/02/2017

[View](/sl/documents/product-information/optaflu-epar-product-information_sl.pdf)

Suomi (FI) (701.65 KB - PDF)

**First published:**

11/05/2009

**Last updated:**

13/02/2017

[View](/fi/documents/product-information/optaflu-epar-product-information_fi.pdf)

svenska (SV) (699.18 KB - PDF)

**First published:**

11/05/2009

**Last updated:**

13/02/2017

[View](/sv/documents/product-information/optaflu-epar-product-information_sv.pdf)

**Latest procedure affecting product information:** T/0091 12/12/2016

icon globe

<!-- image -->

This medicine's product information is available in all **official EU languages** . Select 'available languages' to access the language you need.

Product information documents contain:

- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).

Optaflu : EPAR - All Authorised presentations

English (EN) (461.19 KB - PDF)

**First published:** 12/09/2008

**Last updated:** 22/09/2015

[View](/en/documents/all-authorised-presentations/optaflu-epar-all-authorised-presentations_en.pdf)

[Other languages (24)](#file-language-dropdown-101)

български (BG) (549.6 KB - PDF)

**First published:**

12/09/2008

**Last updated:**

22/09/2015

[View](/bg/documents/all-authorised-presentations/optaflu-epar-all-authorised-presentations_bg.pdf)

español (ES) (461.58 KB - PDF)

**First published:**

12/09/2008

**Last updated:**

22/09/2015

[View](/es/documents/all-authorised-presentations/optaflu-epar-all-authorised-presentations_es.pdf)

čeština (CS) (507.3 KB - PDF)

**First published:**

12/09/2008

**Last updated:**

22/09/2015

[View](/cs/documents/all-authorised-presentations/optaflu-epar-all-authorised-presentations_cs.pdf)

dansk (DA) (476.45 KB - PDF)

**First published:**

12/09/2008

**Last updated:**

22/09/2015

[View](/da/documents/all-authorised-presentations/optaflu-epar-all-authorised-presentations_da.pdf)

Deutsch (DE) (462.8 KB - PDF)

**First published:**

12/09/2008

**Last updated:**

22/09/2015

[View](/de/documents/all-authorised-presentations/optaflu-epar-all-authorised-presentations_de.pdf)

eesti keel (ET) (461.11 KB - PDF)

**First published:**

12/09/2008

**Last updated:**

22/09/2015

[View](/et/documents/all-authorised-presentations/optaflu-epar-all-authorised-presentations_et.pdf)

ελληνικά (EL) (523.54 KB - PDF)

**First published:**

12/09/2008

**Last updated:**

22/09/2015

[View](/el/documents/all-authorised-presentations/optaflu-epar-all-authorised-presentations_el.pdf)

français (FR) (461.82 KB - PDF)

**First published:**

12/09/2008

**Last updated:**

22/09/2015

[View](/fr/documents/all-authorised-presentations/optaflu-epar-all-authorised-presentations_fr.pdf)

hrvatski (HR) (487.48 KB - PDF)

**First published:**

12/09/2008

**Last updated:**

22/09/2015

[View](/hr/documents/all-authorised-presentations/optaflu-epar-all-authorised-presentations_hr.pdf)

íslenska (IS) (460.45 KB - PDF)

**First published:**

12/09/2008

**Last updated:**

22/09/2015

[View](/is/documents/all-authorised-presentations/optaflu-epar-all-authorised-presentations_is.pdf)

italiano (IT) (461.5 KB - PDF)

**First published:**

12/09/2008

**Last updated:**

22/09/2015

[View](/it/documents/all-authorised-presentations/optaflu-epar-all-authorised-presentations_it.pdf)

latviešu valoda (LV) (505.78 KB - PDF)

**First published:**

12/09/2008

**Last updated:**

22/09/2015

[View](/lv/documents/all-authorised-presentations/optaflu-epar-all-authorised-presentations_lv.pdf)

lietuvių kalba (LT) (492.41 KB - PDF)

**First published:**

12/09/2008

**Last updated:**

22/09/2015

[View](/lt/documents/all-authorised-presentations/optaflu-epar-all-authorised-presentations_lt.pdf)

magyar (HU) (516.83 KB - PDF)

**First published:**

12/09/2008

**Last updated:**

22/09/2015

[View](/hu/documents/all-authorised-presentations/optaflu-epar-all-authorised-presentations_hu.pdf)

Malti (MT) (532.54 KB - PDF)

**First published:**

12/09/2008

**Last updated:**

22/09/2015

[View](/mt/documents/all-authorised-presentations/optaflu-epar-all-authorised-presentations_mt.pdf)

Nederlands (NL) (462.12 KB - PDF)

**First published:**

12/09/2008

**Last updated:**

22/09/2015

[View](/nl/documents/all-authorised-presentations/optaflu-epar-all-authorised-presentations_nl.pdf)

norsk (NO) (461.46 KB - PDF)

**First published:**

12/09/2008

**Last updated:**

22/09/2015

[View](/no/documents/all-authorised-presentations/optaflu-epar-all-authorised-presentations_no.pdf)

polski (PL) (506.93 KB - PDF)

**First published:**

12/09/2008

**Last updated:**

22/09/2015

[View](/pl/documents/all-authorised-presentations/optaflu-epar-all-authorised-presentations_pl.pdf)

português (PT) (461.56 KB - PDF)

**First published:**

12/09/2008

**Last updated:**

22/09/2015

[View](/pt/documents/all-authorised-presentations/optaflu-epar-all-authorised-presentations_pt.pdf)

română (RO) (491.16 KB - PDF)

**First published:**

12/09/2008

**Last updated:**

22/09/2015

[View](/ro/documents/all-authorised-presentations/optaflu-epar-all-authorised-presentations_ro.pdf)

slovenčina (SK) (503.19 KB - PDF)

**First published:**

12/09/2008

**Last updated:**

22/09/2015

[View](/sk/documents/all-authorised-presentations/optaflu-epar-all-authorised-presentations_sk.pdf)

slovenščina (SL) (486.96 KB - PDF)

**First published:**

12/09/2008

**Last updated:**

22/09/2015

[View](/sl/documents/all-authorised-presentations/optaflu-epar-all-authorised-presentations_sl.pdf)

Suomi (FI) (461.13 KB - PDF)

**First published:**

12/09/2008

**Last updated:**

22/09/2015

[View](/fi/documents/all-authorised-presentations/optaflu-epar-all-authorised-presentations_fi.pdf)

svenska (SV) (461.66 KB - PDF)

**First published:**

12/09/2008

**Last updated:**

22/09/2015

[View](/sv/documents/all-authorised-presentations/optaflu-epar-all-authorised-presentations_sv.pdf)

## Product details

Name of medicine Optaflu Active substance influenza virus surface antigens (haemagglutinin and neuraminidase), inactivated, of the following strains:A/California/7/2009 (H1N1)pdm09 - like strain(A/Brisbane/10/2010, wild type)A/Switzerland/9715293/2013 (H3N2) - like strain(A/South Australia/55/2014, wild type)B/Phuket/3073/2013-like strain(B/Utah/9/2014, wild type) International non-proprietary name (INN) or common name influenza vaccine (surface antigen, inactivated, prepared in cell cultures) Therapeutic area (MeSH)

- Influenza, Human
- Immunization

Anatomical therapeutic chemical (ATC) code J07BB02

### Pharmacotherapeutic group

Vaccines

### Therapeutic indication

Prophylaxis of influenza for adults, especially in those who run an increased risk of associated complications.

Optaflu should be used in accordance to official guidance.

## Authorisation details

EMA product number EMEA/H/C/000758 Marketing authorisation holder

Seqirus GmbH

Emil-von-Behring Strasse 76

Marketing authorisation issued 01/06/2007 Expiry of marketing authorisation 05/06/2017 Revision 16

## Assessment history

Expand section

Collapse section

## Changes since initial authorisation of medicine

Optaflu : EPAR - Procedural steps taken and scientific information after authorisation

English (EN) (809.01 KB - PDF)

**First published:** 11/05/2009

**Last updated:** 13/02/2017

[View](/en/documents/procedural-steps-after/optaflu-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf)

Optaflu-H-C-PSUSA-00001745-201504 : EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation

Reference Number: EMA/146531/2016

English (EN) (523.75 KB - PDF)

**First published:** 18/03/2016

**Last updated:** 18/03/2016

[View](/en/documents/scientific-conclusion/optaflu-h-c-psusa-00001745-201504-epar-scientific-conclusions-and-grounds-recommending-variation-terms-marketing-authorisation_en.pdf)

Optaflu-H-C-758-P46-0052 : EPAR - Assessment Report

Adopted

Reference Number: EMA/CHMP/538134/2015

English (EN) (3.86 MB - PDF)

**First published:** 10/08/2015

**Last updated:** 10/08/2015

[View](/en/documents/variation-report/optaflu-h-c-758-p46-0052-epar-assessment-report_en.pdf)

Optaflu-H-C-758-P-46-0053 : EPAR - Assessment Report

Adopted

Reference Number: EMA/250256/2015

English (EN) (4.13 MB - PDF)

**First published:** 27/04/2015

**Last updated:** 27/04/2015

[View](/en/documents/variation-report/optaflu-h-c-758-p-46-0053-epar-assessment-report_en.pdf)

Optaflu-H-C-758-PSUV-0070 : EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation

Reference Number: EMA/CHMP/26383/2015

English (EN) (517.47 KB - PDF)

**First published:** 06/02/2015

**Last updated:** 06/02/2015

[View](/en/documents/scientific-conclusion/optaflu-h-c-758-psuv-0070-epar-scientific-conclusions-and-grounds-recommending-variation-terms-marketing-authorisation_en.pdf)

## Initial marketing authorisation documents

Optaflu : EPAR - Procedural steps taken before authorisation

English (EN) (491.19 KB - PDF)

**First published:** 01/08/2007

**Last updated:** 01/08/2007

[View](/en/documents/procedural-steps/optaflu-epar-procedural-steps-taken-authorisation_en.pdf)

Optaflu : EPAR - Scientific Discussion

English (EN) (1011.19 KB - PDF)

**First published:** 01/08/2007

**Last updated:** 01/08/2007

[View](/en/documents/scientific-discussion/optaflu-epar-scientific-discussion_en.pdf)

#### More information on Optaflu

- [EMEA-000124-PIP01-07-M02 - paediatric investigation plan](/en/medicines/human/paediatric-investigation-plans/emea-000124-pip01-07-m02)

**This page was last updated on** 27/06/2017

## Share this page

[Back to top](#main-content)